Amendment No. 5 to Schedule 13D for Rani Therapeutics Holdings, Inc.

Amendment No. 5 to the Schedule 13D filed by South Cone Investments Limited Partnership, South Lake One LLC, and South Lake Management LLC updates their beneficial ownership of Class A Common Stock of Rani Therapeutics Holdings, Inc. The amendment reports that South Lake One sold 1,923,000 shares on October 20, 2025, and 4,000,000 shares on October 21, 2025, reducing their ownership below 5%. The Reporting Persons acquired and hold the shares for investment purposes and may acquire or dispose of additional securities in the future based on various factors, including the Issuer's business prospects and market conditions. As of October 21, 2025, the Reporting Persons ceased to be beneficial owners of more than 5% of the outstanding shares.